Prostate cancer: open trials in France

109 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Centre Hospitalier de la Cote Basque, Bayonne · Centre Jean Perrin, Clermont Ferrand Cedex1 · Centre Oscar Lambret, Lille · Centre Hospitalier Universitaire de Nîmes, Nîmes · Assistance Publique Hopitaux de Paris, Paris · Centre De Lutte Contre Le Cancer Eugene Marquis, Rennes Cedex · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Institut Gustave Roussy, Villejuif
Registry updated 2026-11-05
NCT07766122
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU
Trial Treatment · Phase 4 · University Hospital, Toulouse
Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2026-11-05
NCT06122584
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
Trial Treatment · Phase 3 · ABX advanced biochemical compounds GmbH
CHRU de Nancy, Nancy
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Gustave Roussy (IGR), Villejuif
Registry updated 2026-11-04
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Centre Hospitalier Universitaire de Lille, Lille · Institut Paoli-Calmettes, Marseille · Centre Hospitalier Universitaire de Nantes, Nantes · Institut Curie, Paris · Oncopole Claudius Regaud, Toulouse · Institut Gustave Roussy, Villejuif
Registry updated 2026-11-04
NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Curie, Paris · Institut de Cancerologie de l'Ouest - site St-Herblain, Saint-Herblain
Registry updated 2026-11-04
NCT05800665
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Trial Treatment · Phase 1 · Genentech, Inc.
Centre Leon Berard, Lyon · Institut Paoli-Calmettes, Marseille · Institut Gustave Roussy, Villejuif
Registry updated 2026-11-03
NCT06095089
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Institut Bergonie, Bordeaux · Centre Leon Berard, Lyon · Institut Gustave Roussy, Villejuif
Registry updated 2026-11-03
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Institut Bergonie, Bordeaux · Centre Hospitalier Régional et Universitaire de Brest, Brest · Centr Georges Francois Leclerc, Dijon · Centre Oscar Lambret, Lille · Centre Leon Berard, Lyon · Fondation Hôpital Saint-Joseph, Paris · Hospices Civils de Lyon, Pierre-Bénite · Institut De Cancerologie De L Ouest, Saint-Herblain Cedex · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Oncopole Claudius Regaud, Toulouse · Institut de cancérologie de Lorraine, Vandoeuvre Les Nancy_ Cedex · Institut Gustave Roussy, Villejuif
Registry updated 2026-11-03
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Institut Bergonie, Bordeaux · Centre Jean Perrin, Clermont-Ferrand · Centre Oscar Lambret, Lille · Centre Leon Berard, Lyon · Centre Hospitalier Universitaire De Nimes, Nimes Cedex 9 · Assistance Publique Hopitaux de Paris, Paris · Centre De Lutte Contre Le Cancer Eugene Marquis, Rennes Cedex · Institut Gustave Roussy, Villejuif
Registry updated 2026-11-03
NCT07451002
A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
Research · Janssen Cilag S.A.S.
Centre François Baclesse, Caen
Registry updated 2026-11-03
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Institut Bergonie, Bordeaux · Centre Hospitalier Régional et Universitaire de Brest, Brest · Centre Jean Perrin, Clermont Ferrand Cedex1 · Clinique Victor Hugo, Le Mans · Centre Leon Berard, Lyon · Hospices Civils de Lyon, Pierre-Bénite · Institut Godinot, Reims · Centre Hospitalier Prive Saint Gregoire, Saint-Grégoire · Institut De Cancerologie De L Ouest, Saint-Herblain Cedex · Les Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre, Strasbourg
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Centre Francois Baclesse, Caen Cedex 5 · Polyclinique De Limoges, Limoges Cedex I · Hôpital Privé Clairval, Marseille · Centre Hospitalier Universitaire De Nimes, Nimes Cedex 9 · Hopital Saint Louis, Paris · Centre Hospitalier Universitaire Rouen, Rouen Cedex · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Hospital Foch, Suresnes · Institut de cancérologie de Lorraine, Vandoeuvre Les Nancy_ Cedex
Registry updated 2026-10-30
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Hospices Civils De Lyon (hcl) -Centre Hospitalier Lyon-Sud, Pierre-Bénite
Registry updated 2026-10-30
NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Pierre-Bénite
Registry updated 2026-10-29
NCT07332455
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Montpellier · Villejuif
Registry updated 2026-10-28
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
CHU Bordeaux, Bordeaux · Centre Georges Franăois Leclerc, Dijon · Hopital Claude Huriez - Chu Lille, Lille · Centre Leon Berard, Lyon · Hăpital de La Timone, Marseille · Chu Nantes - Hătel Dieu, Nantes · Institut Claudius Regaud, Toulouse · ICL - Alexis Vautrin, Vandœuvre-lès-Nancy · Institut Gustave Roussy, Villejuif
Registry updated 2026-10-26
NCT07244341
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 1 · Daiichi Sankyo
Centre Oscar Lambret, Lille · Centre Leon Berard, Lyon
Registry updated 2026-10-26
2025-524080-20-00
A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
Trial Treatment · Phase 1 · Novartis Pharma AG
Institut Bergonie, Bordeaux
Registry updated 2026-10-23
NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 1/2 · AstraZeneca
Lyon · Montpellier · Saint-Herblain · Suresnes · Villejuif
Registry updated 2026-10-22
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Institut de Cancerologie de L'Ouest, Angers · Institut Bergonie, Bordeaux · Hospices Civils de Lyon, Bron · Centre Jean Perrin, Clermont-Ferrand · Institut Curie, Paris · Centre Henri Becquerel, Rouen · Institut Curie, Saint-Cloud · Institut De Cancerologie De L Ouest, Saint-Herblain Cedex
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Institut Bergonie, Bordeaux · Centre Hospitalier Regional Et Universitaire De Brest, Brest Cedex 2 · Centre Jean Perrin, Clermont Ferrand Cedex1 · HPM Nord, Lille · Centre Leon Berard, Lyon · GIE Groupe hospitalier Paris Saint-Joseph/Vinci, Paris · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Hospital Foch, Suresnes · Institut Gustave Roussy, Villejuif
Registry updated 2026-10-20
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre, Bordeaux · Institut Bergonie, Bordeaux · Centre Regional Francois Baclesse, Caen · Centre Jean Perrin, Clermont-Ferrand · Clinique Victor Hugo - Centre Jean Bernard, Le Mans · Centre Leon Berard, Lyon · Centre Antoine Lacassagne, Nice · Hôpital Européen Georges Pompidou, Paris · Groupe hospitalier Paris saint Joseph, Paris · Centre Hospitalier Universitaire de Strasbourg - Hopital de Hautepierre, Strasbourg · Hopital Foch, Suresnes · Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse · Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy · Gustave Roussy, Villejuif
Registry updated 2026-10-20
NCT07344779
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-19
NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Trial Treatment · Phase 3 · AstraZeneca
Villejuif
Registry updated 2026-10-19

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error